市值: $3.3012T 0.460%
體積(24小時): $163.9614B 28.200%
  • 市值: $3.3012T 0.460%
  • 體積(24小時): $163.9614B 28.200%
  • 恐懼與貪婪指數:
  • 市值: $3.3012T 0.460%
加密
主題
加密植物
資訊
加密術
影片
頭號新聞
加密
主題
加密植物
資訊
加密術
影片
bitcoin
bitcoin

$105398.502299 USD

1.75%

ethereum
ethereum

$2555.207592 USD

3.43%

tether
tether

$1.000429 USD

-0.02%

xrp
xrp

$2.141971 USD

2.09%

bnb
bnb

$651.827388 USD

1.41%

solana
solana

$146.611988 USD

2.90%

usd-coin
usd-coin

$0.999805 USD

-0.01%

dogecoin
dogecoin

$0.177273 USD

3.19%

tron
tron

$0.271470 USD

0.86%

cardano
cardano

$0.634997 USD

1.86%

hyperliquid
hyperliquid

$41.657613 USD

9.72%

sui
sui

$3.026449 USD

2.34%

bitcoin-cash
bitcoin-cash

$444.966315 USD

11.29%

chainlink
chainlink

$13.256001 USD

2.72%

unus-sed-leo
unus-sed-leo

$9.032403 USD

1.94%

加密貨幣新聞文章

Evertz Pharma GmbH成為德國第一家採用戰略比特幣儲備模型的公司

2025/06/11 23:58

Evertz Pharma GmbH是一家專注於高級天然化妝品的公司,已成為德國第一家採用戰略性比特幣儲備模型的公司

Evertz Pharma GmbH, a company renowned for its premium natural cosmetics, has become the first company in Germany to adopt a strategic Bitcoin reserve model.

Evertz Pharma GmbH是一家以其優質天然化妝品而聞名的公司,已成為德國第一家採用戰略性比特幣儲備模式的公司。

According to a press release, the company purchased an additional 100 BTC in May 2025, an amount that is valued at approximately €10 million ($10.8 million).

根據新聞稿,該公司在2025年5月購買了另外100 BTC,價值約為1000萬歐元(1080萬美元)。

The adoption marks a continued expansion of the company’s BTC treasury, which began in December 2020 with an initial €2 million Bitcoin purchase.

採用標誌著該公司的BTC財政部的持續擴展,該財政部始於2020年12月,最初€200萬歐元的比特幣購買。

Since then, Evertz Pharma has regularly allocated corporate profits toward Bitcoin, building a digital reserve aimed at long-term stability.

從那時起,Evertz Pharma定期將公司利潤分配給比特幣,建立了旨在長期穩定性的數字儲備。

“Our mission is to promote natural beauty on a scientific foundation,” said Dominik Evertz, Managing Director of Evertz Pharma GmbH. “The same future-focused mindset shapes our financial strategy: Bitcoin, as a scarce and globally tradable asset, complements our reserves and strengthens the long-term resilience of our company.”

Evertz Pharma GmbH董事總經理Dominik Evertz說:“我們的使命是在科學基礎上促進自然美景。” “同樣以未來為中心的思維方式塑造了我們的財務戰略:比特幣,作為稀缺且全球可貿易的資產,可以補充我們的儲備,並增強了我們公司的長期韌性。”

The company’s latest acquisition of 100 BTC distinguishes it from industry peers and traditional treasury strategies.

該公司對100 BTC的最新收購將其與行業同行和傳統財政策略區分開。

Tobias Evertz, Group CFO stated, “We will continue to invest corporate profits in Bitcoin and are constantly evaluating additional ways to increase our holdings sustainably.”

CFO集團托比亞斯·埃弗茨(Tobias Evertz)表示:“我們將繼續將公司利潤投資於比特幣,並不斷評估其他方法以可持續增加我們的持股。”

Unlike publicly traded Bitcoin adopters such as Strategy and Metaplanet, Evertz Pharma operates as a privately held German enterprise.

與諸如戰略和Metaplanet之類的公開交易比特幣採用者不同,Evertz Pharma是一家私有的德國企業。

“Bitcoin is not just an investment for us but a strategic asset that perfectly complements our vision of stability and future resilience. At the same time, we are aligning our financial strategy with the needs of a modern, sustainably operating company,” added Dominik Evertz.

“比特幣不僅是我們的投資,而且是一種完美地補充我們穩定和未來韌性願景的戰略資產。與此同時,我們將財務戰略與現代,可持續運營的公司的需求保持一致,” Dominik Evertz補充說。

Everetz explains that Bitcoin is a store of value, a hedge against inflation, and a means to diversify reserves. It allows Evertz Pharma to preserve capital without the storage burdens that come with traditional assets like gold. The company’s treasury strategy shows their commitment to financial sustainability.

Everetz解釋說,比特幣是一種價值存儲,抵抗通貨膨脹的對沖,也是多元化儲量的手段。它允許Evertz Pharma保留資本,而無需帶有金牌等傳統資產的存儲負擔。該公司的國庫策略顯示了他們對財務可持續性的承諾。

免責聲明:info@kdj.com

所提供的資訊並非交易建議。 kDJ.com對任何基於本文提供的資訊進行的投資不承擔任何責任。加密貨幣波動性較大,建議您充分研究後謹慎投資!

如果您認為本網站使用的內容侵犯了您的版權,請立即聯絡我們(info@kdj.com),我們將及時刪除。

2025年06月15日 其他文章發表於